12-111418609-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005475.3(SH2B3):c.464C>T(p.Pro155Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000519 in 1,489,000 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00036 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 1 hom. )
Consequence
SH2B3
NM_005475.3 missense
NM_005475.3 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 1.31
Genes affected
SH2B3 (HGNC:29605): (SH2B adaptor protein 3) This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.008155733).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SH2B3 | NM_005475.3 | c.464C>T | p.Pro155Leu | missense_variant | 2/8 | ENST00000341259.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SH2B3 | ENST00000341259.7 | c.464C>T | p.Pro155Leu | missense_variant | 2/8 | 1 | NM_005475.3 | P1 | |
SH2B3 | ENST00000550925.2 | c.272C>T | p.Pro91Leu | missense_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000362 AC: 55AN: 151766Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
55
AN:
151766
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000320 AC: 38AN: 118718Hom.: 0 AF XY: 0.000294 AC XY: 20AN XY: 68010
GnomAD3 exomes
AF:
AC:
38
AN:
118718
Hom.:
AF XY:
AC XY:
20
AN XY:
68010
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000537 AC: 718AN: 1337126Hom.: 1 Cov.: 33 AF XY: 0.000500 AC XY: 331AN XY: 662498
GnomAD4 exome
AF:
AC:
718
AN:
1337126
Hom.:
Cov.:
33
AF XY:
AC XY:
331
AN XY:
662498
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000362 AC: 55AN: 151874Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74248
GnomAD4 genome
AF:
AC:
55
AN:
151874
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74248
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
28
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 30, 2021 | This sequence change has been previously described in a patient with overhydrated stomatocytes and was classified as a variant of unknown significance (PMID: 31298594). This sequence change has been described in the gnomAD database with a low population frequency of 0.033% (dbSNP rs531156627). The p.Pro155Leu change affects a highly conserved amino acid residue located in a domain of the SH2B3 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Pro155Leu substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Pro155Leu change remains unknown at this time. - |
Thrombocythemia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Dec 14, 2022 | This SH2B3 missense variant has been reported in two individuals, one with idiopathic erythrocytosis, and the other with overhydrated stomatocytosis. c.464C>T (rs531156627) has an entry in ClinVar4 (Variation ID 1336169), and is rare (<0.1%) in a large population dataset (gnomAD v3.1.2: 55/151766 total alleles; 0.036%; no homozygotes). Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the other predicts that it would be tolerated, and the proline residue at this position is evolutionarily conserved across many of the species assessed. We consider the clinical significance of c.464C>T; p.Pro155Leu in SH2B3 to be uncertain at this time. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
N
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at